After a busy few days of ASHRAE committee meetings at the 2025 Winter Conference, I had an opportunity to attend at the AHR Expo in Orlando. This is a show I try to attend every year to experience first hand how science-backed air purification can transform indoor environments and have a positive impact on Indoor Environmental Quality IEQ, not just IAQ. One booth I always like to stop by is the Fellowes booth to see how the AeraMax™ air purifiers, independently tested by Airmid Healthgroup, have been validated to remove airborne viruses and improve air quality.
L-R: Beth Benton Wright, Ethan Fridman, Arti Lyde, and Dr. John McKeon at the GBAC Summit in Chicago
The last time I met with the team was at Design Days in 2024 where I had an opportunity to catch up with John Fellowes the CEO.
John Fellowes and Dr.John McKeon
Case Study: Fellowes AeraMax™ Air Purifiers – Validated for Healthier Indoor Air
Opportunity
Fellowes, a leader in workplace solutions, recognized the growing demand for scientifically validated air purifiers that effectively capture airborne pathogens. To strengthen consumer confidence and differentiate their AeraMax™ air purifiers, they sought independent third-party validation of their ability to remove airborne influenza and cold viruses.
Our Approach
Airmid Healthgroup conducted rigorous, independent testing of Fellowes AeraMax™ air purifiers under controlled laboratory conditions, focusing on:
1. Pathogen Testing – Simulating indoor environments to assess the purifiers’ ability to capture and eliminate airborne influenza and cold viruses.
2. Technology Assessment – Evaluating the True HEPA filtration system’s ability to capture 99.97% of airborne particles, including viruses, dust, mold, and allergens.
Outcome
Testing has confirmed that Fellowes AeraMax™ air purifiers effectively reduce airborne concentrations of influenza and cold viruses.
The HEPA filters were validated to capture 99.97% of airborne particles, reinforcing their role in promoting healthier indoor air quality.
Impact
This independent validation provided Fellowes with credible, science-based evidence of their products’ effectiveness, bolstering consumer trust and differentiating AeraMax™ in the competitive air purification market.
It also underscored the importance of air purification as a key component of cold and flu prevention strategies alongside traditional hygiene practices.
By partnering with Airmid Healthgroup, Fellowes not only demonstrated the efficacy of their AeraMax™ air purifiers but also reinforced their commitment to enhancing public health through improved indoor air quality.
Dr. John McKeon and James Richardson
If you’re attending the AHR Expo, visit the Fellowes booth to see the results for yourself and learn more about the science behind Fellowes AeraMax™ air purifiers.
Airmid Healthgroup is a leading biomedical contract research organization specializing in aerobiology and indoor air quality. We assist global companies like Fellowes, in developing, innovating, and validating products aimed at enhancing indoor environments. Our state-of-the-art laboratories, including climate-controlled environmental chambers, enable precise testing of airborne pollutants, allergens, viruses, and bacteria. With ISO/IEC 17025:2017 accredited allergen and virology labs, we also provide GLP based projects with reliable data for health-based marketing claims. Our multidisciplinary team of scientists and health experts is dedicated to advancing public health by minimizing exposure to indoor air pollutants.
